Related Experiment Video
Updated: Jul 17, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Hepatocellular carcinoma development in cirrhosis
1Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo 162-8666, Japan. okuda@ige.twmu.ac.jp
Hepatocellular carcinoma (HCC) development is complex, influenced by cirrhosis and hepatitis viruses. Early screening improves treatment but requires cost-effectiveness analysis for optimal management of this liver cancer.
Area of Science:
- Hepatology
- Oncology
- Viral Hepatitis Research
Background:
- Hepatocellular carcinoma (HCC) development is multifactorial, with cirrhosis recognized as a significant pre-neoplastic condition.
- The global incidence of HCC varies by hepatitis virus type, and comprehensive data remains limited.
- Hepatocarcinogenesis is a poorly understood, multistep process involving numerous genetic alterations.
Purpose of the Study:
- To discuss the development, mechanisms, prevention, and screening of hepatocellular carcinoma (HCC).
- To highlight the role of cirrhosis as a precursor to HCC.
- To emphasize the importance of early detection and screening for improving HCC patient management.
Main Methods:
- Literature review and synthesis of current knowledge on HCC pathogenesis.
- Discussion of preventive strategies, including interferon therapy for chronic hepatitis C.
- Analysis of screening approaches for early HCC detection.
Main Results:
- Cirrhosis is a key pre-neoplastic condition for HCC development.
- Hepatocarcinogenesis involves complex genetic alterations.
- Interferon may prevent HCC in chronic hepatitis C patients.
- Screening is crucial for early detection and curative treatment application.
Conclusions:
- Effective management of HCC relies on early detection through screening.
- Further analysis of the cost-effectiveness of screening strategies is necessary.
- Understanding hepatocarcinogenesis mechanisms is vital for future prevention and treatment development.
More Related Videos
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Hepatitis
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow